Leptin receptor deficiency confers resistance to behavioral effects of fluoxetine and desipramine via separable substrates.
Leptin receptor deficiency confers resistance to behavioral effects of fluoxetine and desipramine via separable substrates.
复制标题
瘦素受体缺陷通过可分离的底物导致对氟西汀和地昔帕明行为效应的抵抗
DOI:
10.1038/tp.2014.126
复制
发表时间:
2014-12-02
影响因子:
6.8
通讯作者:
Lu XY
中科院分区:
文献类型:
--
作者:
Guo M;Lu XY
Depression is a complex, heterogeneous mental disorder. Currently available antidepressants are only effective in about one-third to one-half of all patients. The mechanisms underlying antidepressant response and treatment resistance are poorly understood. Recent clinical evidence implicates the involvement of leptin in treatment response to antidepressants. In this study, we determined the functional role of the leptin receptor (LepRb) in behavioral responses to the selective serotonergic antidepressant fluoxetine and the noradrenergic antidepressant desipramine. While acute and chronic treatment with fluoxetine or desipramine in wild-type mice elicited antidepressant-like effects in the forced swim test, mice null for LepRb (db/db) displayed resistance to treatment with either fluoxetine or desipramine. Fluoxetine stimulated phosphorylation of Akt (Thr308) and GSK-3β (Ser9) in the hippocampus and prefrontal cortex (PFC) of wild-type mice but not in db/db mice. Desipramine failed to induce measurable changes in Akt, GSK-3β or ERK1/2 phosphorylation in the hippocampus and PFC, as well as hypothalamus of either genotype of mice. Deletion of LepRb specifically from hippocampal and cortical neurons resulted in fluoxetine insensitivity in the forced swim test and tail suspension test while leaving the response to desipramine intact. These results suggest that functional LepRb is critically involved in regulating the antidepressant-like behavioral effects of both fluoxetine and desipramine. The antidepressant effects of fluoxetine but not desipramine are dependent on the presence of functional LepRb in the hippocampus and cortex.
登录
查看更多内容
DOI:
10.1136/bmj.b3765
发表时间:
2009-10-06
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Kivimäki M;Lawlor DA;Singh-Manoux A;Batty GD;Ferrie JE;Shipley MJ;Nabi H;Sabia S;Marmot MG;Jokela M
通讯作者:
Jokela M
影响因子:
29
作者:
Lam DD;Leinninger GM;Louis GW;Garfield AS;Marston OJ;Leshan RL;Scheller EL;Christensen L;Donato J Jr;Xia J;Evans ML;Elias C;Dalley JW;Burdakov DI;Myers MG Jr;Heisler LK
通讯作者:
Heisler LK
DOI:
10.1017/s1461145712000703
发表时间:
2013-05
期刊:
The international journal of neuropsychopharmacology
影响因子:
--
作者:
Guo M;Huang TY;Garza JC;Chua SC;Lu XY
通讯作者:
Lu XY
影响因子:
6.9
作者:
Chen, G;Manji, HK
通讯作者:
Manji, HK
影响因子:
6.8
作者:
Guo M;Lu Y;Garza JC;Li Y;Chua SC;Zhang W;Lu B;Lu XY
通讯作者:
Lu XY